Detail
| LncRNA Name | NNT-AS1 |
| Synonyms | NA |
| Region | GRCh38_5:43571594-43603230 Sequence |
| Ensembl | ENSG00000248092 |
| RefSeq | NR_073113 |
| Circulating | ✘ |
| Drug-resisitant | ✘ |
| Prognostic | ✘ |
| MiRNA | ✔ |
| Variant | ✘ |
| TF | ✘ |
| Methylation | ✘ |
| Cancer Name | lung cancer |
| ICD-0-3 | C34 |
| Methods | qPCR etc. |
| Sample | lung cancer tissues, cell lines (H1299, H23, A549, SPC-A-1, and H522) |
| Expression Pattern | differential expression |
| Function Description | Thus, our study indicated that lncRNA NNT-AS1 exerted functions in NSCLC via altering NNT-AS1/miR-129-5p axis which provided a novel therapeutic target for lung cancer treatment. |
| Pubmed ID | 29857296 |
| Year | 2018 |
| Title | LncRNA NNT-AS1 promotes the proliferation, and invasion of lung cancer cells via regulating miR-129-5p expression |
| External Links |
| Links for NNT-AS1 | GenBank HGNC lncrnadb Noncode |
| Links for lung cancer | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.